Health Care & Life Sciences » Pharmaceuticals | Korean Drug Co. Ltd.

Korean Drug Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
709
2,151
1,774
5,050
4,683
Depreciation, Depletion & Amortization
955
966
965
922
954
Other Funds
1,265
2,140
871
2,171
1,082
Funds from Operations
2,930
5,257
3,610
8,143
6,720
Changes in Working Capital
1,192
793
2,523
4,180
6,272
Net Operating Cash Flow
4,121
4,463
6,133
3,963
447
Capital Expenditures
401
721
878
461
1,140
Sale of Fixed Assets & Businesses
2
-
-
5
45
Purchase/Sale of Investments
15
1
928
953
1,006
Net Investing Cash Flow
763
295
1,832
1,170
114
Cash Dividends Paid - Total
770
657
766
765
1,091
Issuance/Reduction of Debt, Net
1,500
3,500
3,500
2,000
-
Net Financing Cash Flow
2,440
4,157
4,349
2,870
1,082
Net Change in Cash
918
11
48
73
749
Free Cash Flow
3,745
3,925
5,585
3,521
685
Other Sources
8
1,049
1,233
1,415
202
Change in Capital Stock
170
-
83
105
9
Exchange Rate Effect
-
-
-
3
-
Other Uses
387
624
1,259
1,176
226

About Korean Drug Co.

View Profile
Address
69-10 Wonjeok-ro
Icheon GY 17303
Korea, Republic Of
Employees -
Website http://www.nicepharma.com
Updated 09/14/2018
Korean Drug Co., Ltd. engages in the research and development, manufacture and sale of pharmaceutical products. Its products are divided into the following categories: Over-The-Counter (OTC), ETC and Health Foods. Its products include remedies for respiratory diseases, topical agents for dermatoses, antibiotics and chemotherapeutics, hypnotics, antiulcer agents, antihistaminic, amino acid nutrients, antifungal agents and home pregnancy test kit.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.